A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries.
Tekijät: Damoiseaux J, Agmon-Levin N, Van Blerk M, Chopyak V, Eriksson C, Heijnen I, Herold M, Høgåsen K, Musset L, Radice A, Rego de Sousa MJ, Viander M, Shoenfeld Y
Julkaisuvuosi: 2014
Journal: Clinical and Experimental Rheumatology
Tietokannassa oleva lehden nimi: Clinical and experimental rheumatology
Lehden akronyymi: Clin Exp Rheumatol
Vuosikerta: 32
Numero: 4
Aloitussivu: 539
Lopetussivu: 546
Sivujen määrä: 8
ISSN: 0392-856X
OBJECTIVES\nOne of the main goals of the European Autoimmunity Standardisation Initiative (EASI) is the harmonisation of test-algorithms for autoantibodies related to systemic autoimmune rheumatic diseases (SARD).\nMETHODS\nA questionnaire was used to gather information on methodology, interpretation, and the algorithm for detection of anti-nuclear antibodies (ANA) in relation to their antigen-specificity. The questionnaire was sent to 1200 laboratories in 12 European countries.\nRESULTS\nThe response rate was 47.2%. The results reveal not only apparent differences between countries, but also within countries.\nCONCLUSIONS\nAwareness of these differences may as such already stimulate harmonisation, but the observed differences may also direct recommendations that may further contribute to achieving the EASI goal of harmonisation of autoimmune diagnostics for SARD.